354 related articles for article (PubMed ID: 25210118)
1. IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-β receptor on hepatic stellate cells in a JNK-dependent manner.
Fabre T; Kared H; Friedman SL; Shoukry NH
J Immunol; 2014 Oct; 193(8):3925-33. PubMed ID: 25210118
[TBL] [Abstract][Full Text] [Related]
2. MiR-142-3p blocks TGF-β-induced activation of hepatic stellate cells through targeting TGFβRI.
Yang X; Dan X; Men R; Ma L; Wen M; Peng Y; Yang L
Life Sci; 2017 Oct; 187():22-30. PubMed ID: 28823564
[TBL] [Abstract][Full Text] [Related]
3. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
[TBL] [Abstract][Full Text] [Related]
4. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
[TBL] [Abstract][Full Text] [Related]
5. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
Marquez-Aguirre A; Sandoval-Rodriguez A; Gonzalez-Cuevas J; Bueno-Topete M; Navarro-Partida J; Arellano-Olivera I; Lucano-Landeros S; Armendariz-Borunda J
J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315
[TBL] [Abstract][Full Text] [Related]
7. Iron Enhances Hepatic Fibrogenesis and Activates Transforming Growth Factor-β Signaling in Murine Hepatic Stellate Cells.
Mehta KJ; Coombes JD; Briones-Orta M; Manka PP; Williams R; Patel VB; Syn WK
Am J Med Sci; 2018 Feb; 355(2):183-190. PubMed ID: 29406047
[TBL] [Abstract][Full Text] [Related]
8. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.
Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H
J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation.
Ma L; Zeng Y; Wei J; Yang D; Ding G; Liu J; Shang J; Kang Y; Ji X
Biomed Pharmacother; 2018 Nov; 107():1728-1735. PubMed ID: 30257391
[TBL] [Abstract][Full Text] [Related]
11. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling.
Zhang K; Zhang YQ; Ai WB; Hu QT; Zhang QJ; Wan LY; Wang XL; Liu CB; Wu JF
World J Gastroenterol; 2015 Jan; 21(3):878-87. PubMed ID: 25624721
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
[TBL] [Abstract][Full Text] [Related]
13. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
14. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury.
Yoshida K; Matsuzaki K; Mori S; Tahashi Y; Yamagata H; Furukawa F; Seki T; Nishizawa M; Fujisawa J; Okazaki K
Am J Pathol; 2005 Apr; 166(4):1029-39. PubMed ID: 15793284
[TBL] [Abstract][Full Text] [Related]
16. CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis.
Cai X; Li Z; Zhang Q; Qu Y; Xu M; Wan X; Lu L
J Cell Mol Med; 2018 Oct; 22(10):5050-5061. PubMed ID: 30106235
[TBL] [Abstract][Full Text] [Related]
17. Probiotics counteract the expression of hepatic profibrotic genes via the attenuation of TGF-β/SMAD signaling and autophagy in hepatic stellate cells.
Kanmani P; Kim H
PLoS One; 2022; 17(1):e0262767. PubMed ID: 35051234
[TBL] [Abstract][Full Text] [Related]
18. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern.
Ruehl M; Erben U; Kim K; Freise C; Dagdelen T; Eisele S; Trowitzsch-Kienast W; Zeitz M; Jia J; Stickel F; Somasundaram R
J Nutr Biochem; 2009 Aug; 20(8):597-606. PubMed ID: 18824344
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation.
Liu Y; Liu H; Meyer C; Li J; Nadalin S; Königsrainer A; Weng H; Dooley S; Ten Dijke P
J Biol Chem; 2013 Oct; 288(42):30708-30719. PubMed ID: 24005672
[TBL] [Abstract][Full Text] [Related]
20. Interaction between insulin-like growth factor binding protein-related protein 1 and transforming growth factor beta 1 in primary hepatic stellate cells.
Li XQ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Liu LX
Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):395-404. PubMed ID: 28823370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
